Section Arrow
ETON.NASDAQ
- Eton Pharmaceuticals
Quotes are at least 15-min delayed:2025/07/04 13:42 EDT
Last
 14.45
-0.03 (-0.21%)
Day High 
14.65 
Prev. Close
14.48 
1-M High
19.02 
Volume 
243.26K 
Bid
14.1
Ask
14.95
Day Low
14.03 
Open
14.53 
1-M Low
13.085 
Market Cap 
388.32M 
Currency USD 
P/E 124 
%Yield -- 
10-SMA 13.86 
20-SMA 14.64 
50-SMA 16.55 
52-W High 21.48 
52-W Low 3.22 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.18/1.68
Enterprise Value
418.24M
Balance Sheet
Book Value Per Share
0.91
Cash Flow
Cash Flow Yield
0.01
Income Statement
Total Revenue
39.01M
Operating Revenue Per Share
1.08
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TLRYTilray Brands0.5387+0.0535+11.03%-- 
RGCRegencell Bioscience Holdings Limited22.99+12.63+121.91%-- 
CGCCanopy Growth Corp1.28+0.09+7.56%-- 
IXHLIncannex Healthcare0.2094+0.0025+1.21%-- 
HLNHaleon plc10.25-0.01-0.10%23.95PE
Quotes are at least 15-min delayed:2025/07/04 13:42 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.